116 related articles for article (PubMed ID: 227153)
1. Percutaneous 17 beta-estradiol in treatment of cancer of prostate.
Steg A; Benoit G
Urology; 1979 Oct; 14(4):373-5. PubMed ID: 227153
[TBL] [Abstract][Full Text] [Related]
2. [Serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone versus prostate specific antigen in patients with localized prostate adenocarcinoma who underwent radical prostatectomy. Radioimmunoassays measurements].
Bantis A; Zissimopoulos A; Athanasiadou P; Gonidi M; Agelonidou E; Strataki A; Matthaios D; Tsartsarakis A
Hell J Nucl Med; 2007; 10(1):56-61. PubMed ID: 17450256
[TBL] [Abstract][Full Text] [Related]
3. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.
Hsing AW; Comstock GW
Cancer Epidemiol Biomarkers Prev; 1993; 2(1):27-32. PubMed ID: 8420607
[TBL] [Abstract][Full Text] [Related]
4. [Effect of hormonal therapy on plasma FSH, LH and testosterone levels in prostatic cancer].
Shirai M; Matsuda S; Mitsukawa S; Nakamura M; Yonezawa K
Nihon Hinyokika Gakkai Zasshi; 1975 Feb; 66(2):59-67. PubMed ID: 1168823
[No Abstract] [Full Text] [Related]
5. Patterns of luteinizing and follicle-stimulating hormone pulsatility in menopausal women: correlation with plasma testosterone level and vasomotor instability episodes.
Fossum GT; Greep N; Kletzky OA
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):795-800. PubMed ID: 7573246
[TBL] [Abstract][Full Text] [Related]
6. Control of prostate growth.
Coffey DS; Isaacs JT
Urology; 1981 Mar; 17(Suppl 3):17-24. PubMed ID: 6163242
[No Abstract] [Full Text] [Related]
7. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
9. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy.
Reinberg A; Smolensky MH; Hallek M; Smith KD; Steinberger E
Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279
[TBL] [Abstract][Full Text] [Related]
10. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
[TBL] [Abstract][Full Text] [Related]
11. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
12. [Value of testosterone, FSH and LH on plasma in patients with prostatic adenoma and carcinoma before and after different hormonal treatments].
Garcia de la Peña E; Ramos F; Horcajada C; Cifuentes Delatte L; Vivanco F
Rev Clin Esp; 1978 Jan; 148(1):19-23. PubMed ID: 76325
[No Abstract] [Full Text] [Related]
13. Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy.
Harper ME; Peeling WB; Cowley T; Brownsey BG; Phillips ME; Groom G; Fahmy DR; Griffiths K
Acta Endocrinol (Copenh); 1976 Feb; 81(2):409-26. PubMed ID: 946155
[TBL] [Abstract][Full Text] [Related]
14. The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate.
Grigsby PW; Perez CA
J Urol; 1986 Apr; 135(4):726-7. PubMed ID: 3083117
[TBL] [Abstract][Full Text] [Related]
15. Estrogens in the seminal vesicle fluid and the effect of exogenous estradiol-17beta on hormonal profile in the male rat.
Saksena SK; Lau IF; Chang MC
Biol Reprod; 1978 May; 18(4):521-6. PubMed ID: 656527
[No Abstract] [Full Text] [Related]
16. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
17. Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitude.
Iliff-Sizemore SA; Ortolano GA; Haisenleder DJ; Dalkin AC; Krueger KA; Marshall JC
Endocrinology; 1990 Dec; 127(6):2876-83. PubMed ID: 1701131
[TBL] [Abstract][Full Text] [Related]
18. [Recent aspects in hormonal diagnosis of polycystic ovaries (PCO)].
Moltz L; Römmler A; Schwartz U; Bidlingmaier F; Hammerstein J
Arch Gynecol; 1979 Jul; 228(1-4):566-7. PubMed ID: 485474
[No Abstract] [Full Text] [Related]
19. Hormonal effects of cessation of estrogen treatment for prostatic carcinoma.
Tomić R; Bergman B
J Urol; 1987 Oct; 138(4):801-3. PubMed ID: 3116281
[TBL] [Abstract][Full Text] [Related]
20. Long-term transdermal dihydrotestosterone therapy: effects on pituitary gonadal axis and plasma lipoproteins.
Vermeulen A; Deslypere JP
Maturitas; 1985 Sep; 7(3):281-7. PubMed ID: 3935902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
